Skip to main content
. 2016 Jun 6;7(28):44076–44083. doi: 10.18632/oncotarget.9854

Table 1. Associations between three SNPs and HBV-related HCC susceptibility.

Genotype HCC patients HBV persistent carriers OR (95% CI) P
(n = 1507) (n = 1560)
N (%) N (%)
rs3757328
G/G 1038 (71.9) 1146 (73.8) 1.00
G/A 362 (25.1) 375 (24.1) 1.07 (0.90-1.26)
A/A 43 (3.0) 33 (2.1) 1.44 (0.91-2.29)
Dominant 1.10 (0.93-1.29) 0.262
Recessive 1.42 (0.90-2.25) 0.134
Additive 1.11 (0.96-1.28) 0.150
rs6940552
G/G 958 (64.2) 1048 (67.5) 1.00
G/A 461 (30.9) 453 (29.2) 1.11 (0.95-1.30)
A/A 73 (4.9) 52 (3.4) 1.54 (1.07-2.22)
Dominant 1.16 (1.00-1.35) 0.055
Recessive 1.49 (1.03-2.14) 0.031
Additive 1.16 (1.03-1.32) 0.018
rs9261204
A/A 853 (58.3) 976 (62.9) 1.00
G/A 521 (35.6) 510 (32.8) 1.17 (1.00-1.36)
G/G 88 (6.0) 67 (4.3) 1.51 (1.08-2.10)
Dominant 1.21 (1.04-1.40) 0.011
Recessive 1.42 (1.03-1.97) 0.034
Additive 1.20 (1.06-1.35) 0.004
Combined genotypes (unfavorable genotypes carried) a
0 784 (55.5) 971 (62.8) 1.00
1-3 553 (39.2) 514 (33.3) 1.34 (1.15-1.56) <0.001
4-6 75 (5.3) 61 (4.0) 1.52 (1.07-2.16) 0.019

Note: The logistic regression analyses were adjusted for age and gender.

a

The combined genotypes were trichotomized according to the unfavorable genotypes carried (rs3757328 AA, rs6940552 AA and rs9261204 GG were considered to be unfavorable genotypes). 0 indicates the presence of no unfavorable genotypes, 1–3 indicating the presence of 1–3 unfavorable genotypes, and 4-6 indicates the presence of 4-6 unfavorable genotypes.